NYSE:ABT • US0028241000
Past quarterly earnings results for ABBOTT LABORATORIES (ABT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1.50 | 1.51 | -0.75% | 11.94% | 11.459B | 11.921B | -3.88% | 4.42% |
| Q3 2025 | 1.30 | 1.31 | -1.06% | 7.44% | 11.369B | 11.518B | -1.29% | 6.90% |
| Q2 2025 | 1.26 | 1.27 | -0.58% | 10.53% | 11.142B | 11.179B | -0.33% | 7.37% |
| Q1 2025 | 1.09 | 1.08 | 0.73% | 11.22% | 10.358B | 10.502B | -1.37% | 3.95% |
| Q4 2024 | 1.34 | 1.36 | -1.16% | 12.61% | 10.974B | 11.122B | -1.33% | 7.16% |
| Q3 2024 | 1.21 | 1.21 | -0.34% | 6.14% | 10.635B | 10.655B | -0.19% | 4.85% |
| Q2 2024 | 1.14 | 1.12 | 2.22% | 5.56% | 10.377B | 10.474B | -0.93% | 4.00% |
| Q1 2024 | 0.98 | 0.96 | 1.61% | -4.85% | 9.964B | 9.979B | -0.15% | 2.23% |
| Q4 2023 | 1.19 | 1.20 | -0.89% | 15.53% | 10.241B | 10.282B | -0.40% | 1.49% |
| Q3 2023 | 1.14 | 1.11 | 2.82% | -0.87% | 10.143B | 9.904B | 2.41% | -2.56% |
| Q2 2023 | 1.08 | 1.06 | 1.87% | -24.48% | 9.978B | 9.795B | 1.87% | -11.36% |
| Q1 2023 | 1.03 | 1.00 | 3.24% | -40.46% | 9.747B | 9.733B | 0.14% | -18.06% |
| Q4 2022 | 1.03 | 0.93 | 11.12% | -21.97% | 10.091B | 9.762B | 3.37% | -12.01% |
| Q3 2022 | 1.15 | 0.95 | 20.60% | -17.86% | 10.41B | 9.777B | 6.47% | -4.74% |
| Q2 2022 | 1.43 | 1.14 | 25.59% | 22.22% | 11.257B | 10.422B | 8.01% | 10.11% |
| Q1 2022 | 1.73 | 1.48 | 16.92% | 31.06% | 11.895B | 11.097B | 7.19% | 13.76% |
| Q4 2021 | 1.32 | 1.22 | 8.36% | -8.97% | 11.468B | 10.815B | 6.04% | 7.17% |
| Q3 2021 | 1.40 | 0.95 | 46.65% | 42.86% | 10.928B | 9.655B | 13.18% | 23.44% |
| Q2 2021 | 1.17 | 1.03 | 13.83% | 105.26% | 10.223B | 9.787B | 4.45% | 39.51% |
| Q1 2021 | 1.32 | 1.29 | 2.59% | 103.08% | 10.456B | 10.793B | -3.12% | 35.34% |
| Q4 2020 | 1.45 | 1.37 | 6.14% | - | 10.701B | 10.035B | 6.64% | - |
| Q3 2020 | 0.98 | 0.92 | 6.89% | - | 8.853B | 8.624B | 2.66% | - |
| Q2 2020 | 0.57 | 0.43 | 33.23% | - | 7.328B | 6.875B | 6.59% | - |
| Q1 2020 | 0.65 | 0.59 | 10.56% | - | 7.726B | 7.415B | 4.19% | - |
Notes
ABBOTT LABORATORIES (ABT) last reported earnings on 1/22/2026.
ABBOTT LABORATORIES (ABT) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, ABBOTT LABORATORIES (ABT) has beaten EPS estimates in 1 out of 4 releases.